Skip to main content
. 2019 May 8;9:7084. doi: 10.1038/s41598-019-43572-1

Figure 3.

Figure 3

Dynamic monitoring of CTC count and their prognostic value for recurrence. (A) Patient A with increased CTC number, biophenotypic and mesenchymal CTC proportion showed HCC recurrence. (B) Patient B was diagnosed with HCC recurrence 4 months after the last CTC test. (C) Patient C was diagnosed with HCC recurrence with continuous decreases of CTC number. (D) CTC count increased continuously and biophenotypic and mesenchymal CTC accounted for most of the CTC in patient D who without recurrence. (E,F) In patient E and patient F, CTC count and proportion of biophenotypic and mesenchymal CTC increased and declined irregularly and no HCC recurrence observed.